Diligence memo · auto-generated · as of July 2, 2026
AltaThera Pharmaceuticals, LLC
AltaThera Pharmaceuticals, LLC looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
AltaThera Pharmaceuticals, LLC operates in Pharmaceuticals, based in CHICAGO.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
AltaThera Pharmaceuticals, LLC has raised $7.6M in disclosed capital across 6 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $3.4M on 2016-12-08.
Most recent recorded round closed around 2019-04-22.
Valuation (modeled)modeled
Provath models AltaThera Pharmaceuticals, LLC at approximately $58M (range $1.2M–$457M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.02× the median modeled value of Seed Pharmaceuticals companies in 2019–2021 (49 peers) — value vs value, same stage and era. Within the normal band (102% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 10 months.
Last raise 7.2 yr ago; this sector typically re-raises about every 13 months.
Silent for over 3× the sector's normal cadence.
The last round was 10.2× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 49% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 46% of those peers.
Closest niche peers: Wiesman Capital & Co., LLC, Curzion Pharmaceuticals, Inc., Providence Therapeutics Inc., EnBiotix, Inc., Metuchen Pharmaceuticals, LLC.
Peoplefiled
12 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.